197 related articles for article (PubMed ID: 18199245)
1. Mood-stabilizing pharmacological treatment in bipolar disorders and risk of suicide.
Søndergård L; Lopez AG; Andersen PK; Kessing LV
Bipolar Disord; 2008 Feb; 10(1):87-94. PubMed ID: 18199245
[TBL] [Abstract][Full Text] [Related]
2. Lithium, anticonvulsants and suicidal behavior in bipolar disorder.
Yerevanian BI; Koek RJ; Mintz J
J Affect Disord; 2003 Feb; 73(3):223-8. PubMed ID: 12547290
[TBL] [Abstract][Full Text] [Related]
3. Self-harm, Unintentional Injury, and Suicide in Bipolar Disorder During Maintenance Mood Stabilizer Treatment: A UK Population-Based Electronic Health Records Study.
Hayes JF; Pitman A; Marston L; Walters K; Geddes JR; King M; Osborn DP
JAMA Psychiatry; 2016 Jun; 73(6):630-7. PubMed ID: 27167638
[TBL] [Abstract][Full Text] [Related]
4. Suicidal Behavior During Lithium and Valproate Treatment: A Within-Individual 8-Year Prospective Study of 50,000 Patients With Bipolar Disorder.
Song J; Sjölander A; Joas E; Bergen SE; Runeson B; Larsson H; Landén M; Lichtenstein P
Am J Psychiatry; 2017 Aug; 174(8):795-802. PubMed ID: 28595491
[TBL] [Abstract][Full Text] [Related]
5. Association between consistent purchase of anticonvulsants or lithium and suicide risk: a longitudinal cohort study from Denmark, 1995-2001.
Smith EG; Søndergård L; Lopez AG; Andersen PK; Kessing LV
J Affect Disord; 2009 Oct; 117(3):162-7. PubMed ID: 19243837
[TBL] [Abstract][Full Text] [Related]
6. The rapid suicide protection of mood stabilizers on patients with bipolar disorder: A nationwide observational cohort study in Taiwan.
Tsai CJ; Cheng C; Chou PH; Lin CH; McInnis MG; Chang CL; Lan TH
J Affect Disord; 2016 May; 196():71-7. PubMed ID: 26919054
[TBL] [Abstract][Full Text] [Related]
7. Suicide risk in patients treated with lithium.
Kessing LV; Søndergård L; Kvist K; Andersen PK
Arch Gen Psychiatry; 2005 Aug; 62(8):860-6. PubMed ID: 16061763
[TBL] [Abstract][Full Text] [Related]
8. Suicide risk in bipolar disorder during treatment with lithium and divalproex.
Goodwin FK; Fireman B; Simon GE; Hunkeler EM; Lee J; Revicki D
JAMA; 2003 Sep; 290(11):1467-73. PubMed ID: 13129986
[TBL] [Abstract][Full Text] [Related]
9. Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease: A Nationwide Population-Based Study.
Kessing LV; Gerds TA; Feldt-Rasmussen B; Andersen PK; Licht RW
JAMA Psychiatry; 2015 Dec; 72(12):1182-91. PubMed ID: 26535805
[TBL] [Abstract][Full Text] [Related]
10. Comparative neurocognitive effects of lithium and anticonvulsants in long-term stable bipolar patients.
Sabater A; García-Blanco AC; Verdet HM; Sierra P; Ribes J; Villar I; Lara MJ; Arnal P; Rojo L; Livianos L
J Affect Disord; 2016 Jan; 190():34-40. PubMed ID: 26480209
[TBL] [Abstract][Full Text] [Related]
11. Case-control analyses of the impact of pharmacotherapy on prospectively observed suicide attempts and completed suicides in bipolar disorder: findings from STEP-BD.
Marangell LB; Dennehy EB; Wisniewski SR; Bauer MS; Miyahara S; Allen MH; Martinez M; Al Jurdi RK; Thase ME
J Clin Psychiatry; 2008 Jun; 69(6):916-22. PubMed ID: 18399724
[TBL] [Abstract][Full Text] [Related]
12. Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort.
Lambert CG; Mazurie AJ; Lauve NR; Hurwitz NG; Young SS; Obenchain RL; Hengartner NW; Perkins DJ; Tohen M; Kerner B
Bipolar Disord; 2016 May; 18(3):247-60. PubMed ID: 27226264
[TBL] [Abstract][Full Text] [Related]
13. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
Dunner DL
J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
[TBL] [Abstract][Full Text] [Related]
15. Sexual Dysfunction and Mood Stabilizers in Long-Term Stable Patients With Bipolar Disorder.
García-Blanco A; García-Portilla MP; Fuente-Tomás L; Batalla M; Sánchez-Autet M; Arranz B; Safont G; Arqués S; Livianos L; Sierra P
J Sex Med; 2020 May; 17(5):930-940. PubMed ID: 32139195
[TBL] [Abstract][Full Text] [Related]
16. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
Sajatovic M; Gerhart C; Semple W
Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.
Schaffer A; Isometsä ET; Tondo L; Moreno DH; Sinyor M; Kessing LV; Turecki G; Weizman A; Azorin JM; Ha K; Reis C; Cassidy F; Goldstein T; Rihmer Z; Beautrais A; Chou YH; Diazgranados N; Levitt AJ; Zarate CA; Yatham L
Aust N Z J Psychiatry; 2015 Sep; 49(9):785-802. PubMed ID: 26185269
[TBL] [Abstract][Full Text] [Related]
18. Trends in prescriptions of lithium and other medications for patients with bipolar disorder in office-based practices in the United States: 1996-2015.
Lin Y; Mojtabai R; Goes FS; Zandi PP
J Affect Disord; 2020 Nov; 276():883-889. PubMed ID: 32739706
[TBL] [Abstract][Full Text] [Related]
19. Newer prophylactic agents for bipolar disorder and their influence on suicidality.
Born C; Dittmann S; Post RM; Grunze H
Arch Suicide Res; 2005; 9(3):301-6. PubMed ID: 16020172
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients.
Rohde C; Köhler-Forsberg O; Nierenberg AA; Østergaard SD
Bipolar Disord; 2023 Jun; 25(4):323-334. PubMed ID: 36751986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
